Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 27 (5) , 485-491
- https://doi.org/10.1016/0028-3908(88)90130-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A major metabolite of Δ1-tetrahydrocannabinol reduces its cataleptic effect in miceCellular and Molecular Life Sciences, 1987
- Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimeticsEuropean Journal of Pharmacology, 1985
- GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: Differences between dorsal and ventral striatumBrain Research, 1984
- Tetrahydrocannabinol potentiates reserpine-induced hypokinesiaPharmacology Biochemistry and Behavior, 1981
- Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepinesPharmacology Biochemistry and Behavior, 1981
- Gabaergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by Δ9-tetrahydrocannabinolNeuropharmacology, 1979
- Effect of muscimol, a gaba-mimetic agent, on dopamine metabolism in the mouse brainLife Sciences, 1977
- Cataleptic action of nitrazepam and brain dopamine function in miceNeuropharmacology, 1977
- Physicochemical Approaches to the Mode of Action of General AnestheticsAnesthesiology, 1972
- Cholinergic- and neuroleptic-induced catalepsy: Modification by lesions in the caudate-putamenNeuropharmacology, 1971